-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Jasper Therapeutics (JSPR)
-
-
-
-
-
-
-
Jasper Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Developments
-
-
-
-
-
-
-
Jasper Therapeutics Reports Fiscal 2022 Financial Results and Provides a Business Update
-
-
-
-
-
-
-
Jasper Therapeutics (JSPR) Reports FY 21 Results, Provides Business Update
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

